Robins, L. N., Mills, J. L. Effects of in utero exposure to street drugs. Am J Pub Health 1993; 83(Suppl):2–32.Google Scholar

Center for Behavioral Health Statistics and Quality. 2014 National Survey on Drug Use and Health: Detailed Tables. Substance Abuse and Mental Health Services Administration, Rockville, MD, 2015.Google Scholar

Patrick, S. W., Schumacher, R. E., Benneyworth, B. D., et al. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA 2012 May 9; 307(18):1934–40.Google Scholar

Substance Abuse and Mental Health Services Administration. A Collaborative Approach to the Treatment of Pregnant Women with Opioid Use Disorders. HHS Publication No. (SMA) 16-4978. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2016. Available at: http://store.samhsa.gov/.Google Scholar

McLellan, T. A., Kuschner, H., Metzger, D., et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 1992; 9:199–213.CrossRefGoogle ScholarPubMed

Jones, H. E., O'Grady, K. E., Malfi, D., Tuten, M. Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. Am J Addict 2008 Sep–Oct; 17(5);372–86.CrossRefGoogle ScholarPubMed

Benningfield, M. M., Arria, A. M., Kaltenbach, K., et al. Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women. Am J Addict 2010; 19:416–21.Google Scholar

Fitzsimons, H., Tuten, M., Vaidya, V., Jones, H. E. Mood disorders affect drug treatment success of drug-dependent pregnant women. J Subst Abuse Treat 2007; 32:19–25.Google Scholar

Jansson, L. M., Svikis, D., Lee, J., et al. Pregnancy and addiction. A comprehensive care model. J Subst Abuse Treat 1996 Jul–Aug; 13(4):321–9.Google Scholar

Dennis, K., Young, N. K., Gardner, S. G. Funding Family-Centered Treatment for Women with Substance Use Disorders. Irvine, CA: Children and Family Futures Inc; 2008. Available at: www.samhsa.gov/sites/default/files/final_funding_paper_508v.pdfGoogle Scholar

Jones, H. E., Finnegan, L. P., Kaltenbach, K. Methadone and buprenorphine for the management of opioid dependence in pregnancy. Drugs 2012 Apr; 72(6):747–7.Google Scholar

Del Campo, E. J., John, D. S., Kauffman, C. C. Evaluation of the 21-day outpatient heroin detoxification. Int J Addict 1977 Oct; 12(7):923–35.CrossRefGoogle ScholarPubMed

Banys, P., Tusel, D. J., Sees, K. L., Reilly, P. M., Delucchi, K. L. Low (40 mg) versus high (80 mg) dose methadone in a 180-day heroin detoxification program. J Subst Abuse Treat. 1994 May–Jun; 11(3):225–32.Google Scholar

Amato, L., Davoli, M., Minozzi, S., et al. Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database Syst Rev 2013 Feb 28; (2):CD003409.Google ScholarPubMed

Zuspan, F. P., Gumpel, J. A., Mejia-Zelaya, A., Madden, J., Davis, R. Fetal stress from methadone withdrawal. Am J Obstet Gynecol. 1975 May 1; 122(1):43–6.Google Scholar

Rementeriá, J. L., Nunag, N. N. Narcotic withdrawal in pregnancy: Stillbirth incidence with a case report. Am J Obstet Gynecol. 1973 Aug 15; 116(8):1152–6.Google Scholar

Center for Substance Abuse Treatment. Detoxification and Substance Abuse Treatment. Treatment Improvement Protocol (TIP) Series 45. DHHS Publication No. (SMA) 06-4131. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2006.Google Scholar

Jones, H. E., Terplan, M., Meyer, M. Medically assisted withdrawal (detoxification): Considering the mother-infant dyad. J Addict Med 2017, Mar/Apr;11(2):90–92.CrossRefGoogle ScholarPubMed

Drugs.com. Available at: www.drugs.com/pregnancy-categories.html. Retrieved January 27, 2017.Google Scholar

Jones, H. E., Deppen, K., Hudak, M. L., et al. Clinical care considerations for opioid-using pregnant and postpartum women: The role of obstetric providers. Am J Obstet Gynecol 2014 Apr; 210(4):302–10.CrossRefGoogle ScholarPubMed

Zuspan, F. P., Gumpel, J. A., Mejia-Zelaya, A., Madden, J., Davis, R. Fetal stress from methadone withdrawal. Am J Obstet Gynecol 1975 May 1; 122(1):43–6.CrossRefGoogle ScholarPubMed

National Institutes of Health. Effective medical treatment of opiate addiction. NIH Consens Statement 1997 Nov 17–19; 15(6):1–38.Google Scholar

Wiegand, S. L., Swortwood, M. J., Huestis, M. A., et al. Naloxone and metabolites quantification in cord blood of prenatally exposed newborns and correlations with maternal concentrations. AJP Rep 2016 Oct; 6(4):e385–e390.Google ScholarPubMed

Bailey, B. Are there teratogenic risks associated with antidotes used in the acute management of poisoned pregnant women? Birth Defects Res A Clin Mol Teratol. 2003 Feb; 67(2):133–40.Google Scholar

Wiegand, S. L., Stringer, E. M., Stuebe, A. M., et al. Buprenorphine and naloxone compared with methadone treatment in pregnancy. Obstet Gynecol 2015 Feb; 125(2):363–8.Google Scholar

Jumah, N. A., Edwards, C., Balfour-Boehm, J., et al. Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population. BMJ Open 2016 Oct 31; 6(10):e011774.Google Scholar

Albright, B., de la Torre, L., Skipper, B., et al. Changes in methadone maintenance therapy during and after pregnancy. J Subst Abuse Treat. 2011 Dec; 41(4):347–53.Google Scholar

McCarthy, J. J., Leamon, M. H., Willits, N. H., Salo, R. The effect of methadone dose regimen on neonatal abstinence syndrome. J Addict Med 2015 Mar–Apr; 9(2):105–10.Google Scholar

Alto, W. A., O'Connor, A. B. Management of women treated with buprenorphine during pregnancy. Am J Obstet Gynecol 2011 Oct; 205(4):302–8.CrossRefGoogle ScholarPubMed

Holbrook, A. M., Baxter, J. K., Jones, H. E., et al. Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine. Addiction 2012 Nov; 107(Suppl 1):83–90.Google Scholar

Jansson, L. M., Di Pietro, J. A., Elko, A., et al. Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: A comparison of fetal neurobehaviors and infant outcomes. Drug Alcohol Depend 2012 May 1; 122(3):213–9.CrossRefGoogle ScholarPubMed

Jansson, L. M., Dipietro, J. A., Velez, M., et al. Maternal methadone dosing schedule and fetal neurobehaviour. J Matern Fetal Neonatal Med 2009 Jan; 22(1):29–35.CrossRefGoogle ScholarPubMed

Salisbury, A. L., Coyle, M. G., O'Grady, K. E., et al. Fetal assessment before and after dosing with buprenorphine or methadone. Addiction 2012 Nov; 107(Suppl 1):36–44.Google Scholar

Gryczynski, J., Mitchell, S. G., Jaffe, J. H. et al. Retention in methadone and buprenorphine treatment among African Americans. J Subst Abuse Treat 2013; 45(3):287–92.Google Scholar

Bell, J. R., Butler, B., Lawrance, A., et al. Comparing overdose mortality associated with methadone and buprenorphine treatment. Drug Alcohol Depend 2009; 104(1–2):73–7.CrossRefGoogle ScholarPubMed

Jones, H. E., Kaltenbach, K., Heil, S., et al. Neonatal abstinence syndrome following methadone or buprenorphine exposure. N Engl J Med 2010 Dec; 363(24):2320–31.Google Scholar

Jones, H. E., Heil, S. H., Tuten, M., et al. Cigarette smoking in opioid-dependent pregnant women: Neonatal and maternal outcomes. Drug Alcohol Depend Aug 2013; 131(3):271–7.Google Scholar

McNicholas, L. F., Holbrook, A. M., O'Grady, K. E., et al. Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication. Addiction 2012 Nov; 107(Suppl 1):91–7.Google Scholar

Reece-Stremtan, S., Marinelli, K. A. ABM clinical protocol #21: guidelines for breastfeeding and substance use or substance use disorder, revised 2015. Breastfeed Med 2015 Apr; 10(3):135–41.Google Scholar

Kaltenbach, K., O'Grady, K. E., Heil, S. H., et al. Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes. Drug and Alcohol 2018 (in press).Google Scholar

Meyer, M. C., Johnston, A. M., Crocker, A. M., Heil, S. H. Methadone and buprenorphine for opioid dependence during pregnancy: A retrospective cohort study. J Addict Med 2015 Mar–Apr; 9(2):81–6.Google Scholar

Kakko, J., Heilig, M., Sarman, I. Buprenorphine and methadone treatment of opiate dependence during pregnancy: Comparison of fetal growth and neonatal outcomes in two consecutive case series. Drug Alcohol Depend 2008 Jul 1; 96(1–2):69–78.Google Scholar

Jones, H. E., O'Grady, K. E., Johnson, R. E., et al. Management of acute post-partum pain in patients maintained on methadone or buprenorphine during pregnancy. Am J Drug Alcohol Abuse 2009 Jan; 35(3):151–6.CrossRefGoogle ScholarPubMed

Jones, H. E., Johnson, R. E., Milio, L. Post-cesarean pain management of patients maintained on methadone or buprenorphine. Am J Addict 2006 May–Jun; 15(3);258–9.Google Scholar

Pace, C. A., Kaminetzky, L. B., Winter, M., et al. Postpartum changes in methadone maintenance dose. J Subst Abuse Treat 2014 Sep; 47(3):229–32.Google Scholar

Gaalema, D. E., Heil, S. H., Badger, G. J., et al. Time to initiation of treatment for neonatal abstinence syndrome in neonates exposed in utero to buprenorphine or methadone. Drug Alcohol Depend. 2013 Nov 1; 133(1):266–9.CrossRefGoogle ScholarPubMed